Supply: Bukhta Yurii / Shutterstock.com
Altamira Therapeutics (NASDAQ:CYTO) inventory is taking off on Thursday regardless of an absence of stories from the RNA-based therapeutics firm.
There aren’t any new press releases from Altamira Therapeutics that designate why the corporate’s shares are rising at present. Likewise, there’s an absence of filings or analyst protection that shines a lightweight on the inventory’s rally.
As a substitute, it appears to be like like heavy buying and selling is behind at present’s motion. As of this writing, greater than 8 million shares of the corporate’s inventory have modified arms. For comparability, CYTO inventory trades near 2 million shares per day on common.
One factor buyers can even word is CYTO’s penny inventory standing. This comes from its low market capitalization of $5.976 million and prior closing worth of 86 cents per share. Which means the corporate’s shares may be extremely risky.
CYTO Inventory Information To Watch
Whereas there’s no Altamira Therapeutics information at present, some is on the way in which. The corporate intends to carry a presentation on the Sidoti Micro-Cap Convention going down Could 10 by means of Could 11. Thomas Meyer, founder, chairman, and CEO of Altamira Therapeutics will lead this presentation.
Buyers that wish to tune into this presentation can achieve this by means of a webcast on the occasion’s web site. Additionally, the presentation begins at 1:00 p.m. and is ready to final for half an hour.
CYTO inventory is up 47.4% on Thursday morning.
Buyers searching for extra of the newest inventory market information will wish to stick round!
InvestorPlace is house to all the hottest inventory market protection merchants have to learn about on Thursday! That features the largest pre-market inventory movers this morning, what’s taking place with Mullen Automotive (NASDAQ:MULN), and extra. You’ll find out all about these subjects on the following hyperlinks!
Extra Thursday Inventory Market Information
On the date of publication, William White didn’t have (both immediately or not directly) any positions within the securities talked about on this article. The opinions expressed on this article are these of the author, topic to the InvestorPlace.com Publishing Tips.
With solely the rarest exceptions, InvestorPlace doesn’t publish commentary about firms which have a market cap of lower than $100 million or commerce lower than 100,000 shares every day. That’s as a result of these “penny shares” are steadily the playground for rip-off artists and market manipulators. If we ever do publish commentary on a low-volume inventory which may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this truth and warn readers of the dangers.
Learn Extra: Penny Shares — The right way to Revenue With out Getting Scammed
